JACC: Clinical Electrophysiology, 2021, 7 (10), pp.1285-1293. ⟨10.1016/j.jacep.2021.02.022⟩
Objectives: This study aimed to assess the impact of pulmonary valve replacement (PVR) on ventricular arrhythmias burden in a population of tetralogy of Fallot (TOF) patients with continuous cardiac monitoring by implantable cardioverter-defibrillators (ICDs). Background: Sudden cardiac death is a major cause of death in TOF, and right ventricular overload is commonly considered to be a potential trigger for ventricular arrhythmias. Methods: Data were analyzed from a nationwide French ongoing study (DAI-T4F) including all TOF patients with an ICD since 2000. Survival data with recurrent events were used to compare the burden of appropriate ICD therapies before and after PVR in patients who underwent PVR over the study period. Results: A total of 165 patients (mean age 42.2 ± 13.3 years, 70.1% male) were included from 40 centers. Over a median follow-up period of 6.8 (interquartile range: 2.5 to 11.4) years, 26 patients (15.8%) underwent PVR. Among those patients, 18 (69.2%) experienced at least 1 appropriate ICD therapy. When considering all ICD therapies delivered before (n = 62) and after (n = 16) PVR, the burden of appropriate ICD therapies was significantly lower after PVR (HR: 0.21; 95% confidence interval [CI]: 0.08 to 0.56; p = 0.002). Respective appropriate ICD therapies rates per 100 person-years were 44.0 (95% CI: 35.7 to 52.5) before and 13.2 (95% CI: 7.7 to 20.5) after PVR (p < 0.001). In the overall cohort, PVR before ICD implantation was also independently associated with a lower risk of appropriate ICD therapy in primary prevention patients (HR: 0.29 [95% CI: 0.10 to 0.89]; p = 0.031). Conclusions: In this cohort of high-risk TOF patients implanted with an ICD, the burden of appropriate ICD therapies was significantly reduced after PVR. While optimal indications and timing for PVR are debated, these findings suggest the importance of considering ventricular arrhythmias in the overall decision-making process. (French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator [DAI-T4F]; NCT03837574).
Francis Bessière, Kévin Gardey, Abdeslam Bouzeman, Guillaume Duthoit, Linda Koutbi, et al.. Impact of Pulmonary Valve Replacement on Ventricular Arrhythmias in Patients With Tetralogy of Fallot and Implantable Cardioverter-Defibrillator. JACC: Clinical Electrophysiology, 2021, 7 (10), pp.1285-1293. ⟨10.1016/j.jacep.2021.02.022⟩ (lien externe). ⟨hal-03233026⟩ (lien externe)
Citations
APA
Bessière, F., Gardey, K., Bouzeman, A., Duthoit, G., Koutbi, L., Labombarda, F., Marquié, C., Gourraud, J.-B., Mondoly, P., Sellal, J. M., Bordachar, P., Hermida, A., Anselme, F., Asselin, A., Audinet, C., Bernard, Y., Boveda, S., Chevalier, P., Clerici, G., … Waldmann, V. (2021). Impact of Pulmonary Valve Replacement on Ventricular Arrhythmias in Patients With Tetralogy of Fallot and Implantable Cardioverter-Defibrillator. In JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2021.02.022
MLA
Bessière, Francis, et al. “Impact of Pulmonary Valve Replacement on Ventricular Arrhythmias in Patients With Tetralogy of Fallot and Implantable Cardioverter-Defibrillator.” JACC: Clinical Electrophysiology, Oct. 2021, https://doi.org/10.1016/j.jacep.2021.02.022.
Chicago
Bessière, Francis, Kévin Gardey, Abdeslam Bouzeman, Guillaume Duthoit, Linda Koutbi, Fabien Labombarda, Christelle Marquié, et al. 2021. “Impact of Pulmonary Valve Replacement on Ventricular Arrhythmias in Patients With Tetralogy of Fallot and Implantable Cardioverter-Defibrillator.” JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2021.02.022.
Harvard
Bessière, F. et al. (2021) “Impact of Pulmonary Valve Replacement on Ventricular Arrhythmias in Patients With Tetralogy of Fallot and Implantable Cardioverter-Defibrillator,” JACC: Clinical Electrophysiology. Available at: https://doi.org/10.1016/j.jacep.2021.02.022.
ISO 690
BESSIÈRE, Francis, GARDEY, Kévin, BOUZEMAN, Abdeslam, DUTHOIT, Guillaume, KOUTBI, Linda, LABOMBARDA, Fabien, MARQUIÉ, Christelle, GOURRAUD, Jean-Baptiste, MONDOLY, Pierre, SELLAL, Jean Marc, BORDACHAR, Pierre, HERMIDA, Alexis, ANSELME, Frédéric, ASSELIN, Anouk, AUDINET, Caroline, BERNARD, Yvette, BOVEDA, Serge, CHEVALIER, Philippe, CLERICI, Gael, DA COSTA, Antoine, DE GUILLEBON, Maxime, DEFAYE, Pascal, ESCHALIER, Romain, GARCIA, Rodrigue, GUENANCIA, Charles, GUY-MOYAT, Benoit, HENAINE, Roland, IRLES, Didier, ISERIN, Laurence, JOURDA, François, LADOUCEUR, Magalie, LAGRANGE, Philippe, LAREDO, Mikael, MANSOURATI, Jacques, MASSOULIÉ, Grégoire, MATHIRON, Amel, MAURY, Philippe, NGUYEN, Cédric, NINNI, Sandro, PERIER, Marie-Cécile, PIERRE, Bertrand, SACHER, Frédéric, WALTON, Camille, WINUM, Pierre, MARTINS, Raphaël, PASQUIÉ, Jean Luc, THAMBO, Jean Benoit, JOUVEN, Xavier, COMBES, Nicolas, DI FILIPPO, Sylvie, MARIJON, Eloi and WALDMANN, Victor, 2021. Impact of Pulmonary Valve Replacement on Ventricular Arrhythmias in Patients With Tetralogy of Fallot and Implantable Cardioverter-Defibrillator [en ligne]. October 2021. Disponible à l'adresse : https://doi.org/10.1016/j.jacep.2021.02.022